Literature DB >> 27127911

l-NAME differential effects on diazepam and flunitrazepam responses of rats in the object recognition test.

Jolanta Orzelska-Gorka1, Sylwia Talarek2, Joanna Listos2, Ewa Kedzierska2, Sylwia Fidecka2.   

Abstract

BACKGROUND: The present study was undertaken to better understand possible interaction(s) between a non-selective nitric oxide inhibitor: N(G)-nitro-l-arginine methyl ester (l-NAME) and benzodiazepines (BZs) in recognition memory.
METHODS: The study was carried out on adult male albino Wistar rats. A novel object recognition (NOR) task was used to evaluate memory process.
RESULTS: Combined administration of l-NAME (50mg/kg, ip) with a threshold dose of DZ (0.25mg/kg) induced amnesic effects in rats, participating in the NOR test. On the other hand, following a combined administration of l-NAME (100mg/kg, ip) with flunitrazepam (FNZ; 0.1mg/kg), it was found out that l-NAME inhibited the amnesic effects of FNZ on rats in the NOR test.
CONCLUSIONS: The obtained results suggest that suppressed NO synthesis may lead to a facilitation of DZ-induced memory impairment but surprisingly may prevent amnesic effect after FNZ in rats, submitted to NOR task.
Copyright © 2016 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.

Entities:  

Keywords:  Diazepam; Flunitrazepam; Rat; Recognition memory; l-NAME

Mesh:

Substances:

Year:  2016        PMID: 27127911     DOI: 10.1016/j.pharep.2016.03.012

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  6 in total

1.  Neurochemical and Behavioral Effects of a New Hallucinogenic Compound 25B-NBOMe in Rats.

Authors:  Adam Wojtas; Monika Herian; Mateusz Skawski; Małgorzata Sobocińska; Alejandro González-Marín; Karolina Noworyta-Sokołowska; Krystyna Gołembiowska
Journal:  Neurotox Res       Date:  2020-12-18       Impact factor: 3.911

2.  The Antipsychotic D2AAK1 as a Memory Enhancer for Treatment of Mental and Neurodegenerative Diseases.

Authors:  Oliwia Koszła; Przemysław Sołek; Sylwia Woźniak; Ewa Kędzierska; Tomasz M Wróbel; Magda Kondej; Aneta Archała; Piotr Stępnicki; Grażyna Biała; Dariusz Matosiuk; Agnieszka A Kaczor
Journal:  Int J Mol Sci       Date:  2020-11-23       Impact factor: 5.923

3.  Tolerance to neurochemical and behavioral effects of the hallucinogen 25I-NBOMe.

Authors:  Monika Herian; Mateusz Skawski; Adam Wojtas; Małgorzata K Sobocińska; Karolina Noworyta; Krystyna Gołembiowska
Journal:  Psychopharmacology (Berl)       Date:  2021-05-25       Impact factor: 4.530

4.  The Importance of L-Arginine:NO:cGMP Pathway in Tolerance to Flunitrazepam in Mice.

Authors:  Sylwia Talarek; Joanna Listos; Jolanta Orzelska-Gorka; Malgorzata Jakobczuk; Jolanta Kotlinska; Grazyna Biala
Journal:  Neurotox Res       Date:  2016-12-12       Impact factor: 3.911

5.  MicroRNA-325-3p prevents sevoflurane-induced learning and memory impairment by inhibiting Nupr1 and C/EBPβ/IGFBP5 signaling in rats.

Authors:  Lili Xu; Qi Xu; Fang Xu; Wenxin Zhang; Qing Chen; Hui Wu; Xinzhong Chen
Journal:  Aging (Albany NY)       Date:  2020-03-19       Impact factor: 5.682

6.  Modification of NO-cGMP Pathway Differentially Affects Diazepam- and Flunitrazepam-Induced Spatial and Recognition Memory Impairments in Rodents.

Authors:  Jolanta Orzelska-Górka; Piotr Bernat; Piotr Tutka; Joanna Listos; Ewa Kędzierska; Sylwia Fidecka; Sylwia Talarek
Journal:  Neurotox Res       Date:  2019-12-02       Impact factor: 3.911

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.